Healthy women test new sotatercept autoinjector in drug comparison study
NCT ID NCT06930664
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 21 times
Summary
This study looked at how two different forms of the drug sotatercept behave in the bodies of 146 healthy women who cannot become pregnant. One form is a liquid given through an autoinjector pen, and the other is a powder that must be mixed before injection. The goal was simply to compare their drug levels over time, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Pharma CR, LLC ( Site 0005)
Miami, Florida, 33147, United States
-
Anaheim Clinical Trials ( Site 0007)
Anaheim, California, 92801, United States
-
Bio-Kinetic Clinical Applications, LLD dba QPS-MO ( Site 0003)
Springfield, Missouri, 65802, United States
-
QPS-MRA, LLC ( Site 0004)
South Miami, Florida, 33143, United States
Conditions
Explore the condition pages connected to this study.